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ABSTRACT: A peptide fragment of the human tau protein which stacks to
form neat cross β-sheet fibrils, resembling that found in pathological
aggregation, 273GKVQIINKKLDL284 (here “R2/WT”), was modified with a
spin-label at the N-terminus. With the resulting peptide, R2/G273C-SL, we
probed events at time scales spanning seconds to hours after aggregation is
initiated using transmission electron microscopy (TEM), thioflavin T (THT)
fluorescence, ion mobility mass spectrometry (IMMS), electron paramagnetic
resonance (EPR), and Overhauser dynamic nuclear polarization (ODNP) to
determine if deliberate changes to its conformational states and population in
solution influence downstream propensity to form fibrillar aggregates. We find
varying solution conditions by adding the osmolyte urea or TMAO, or simply
using different buffers (acetate buffer, phosphate buffer, or water), produces
significant differences in early monomer/dimer populations and conformations.
Crucially, these characteristics of the peptide in solution state before aggregation
is initiated dictate the fibril formation propensity af ter aggregation. We conclude the driving forces that accelerate aggregation,
when heparin is added, do not override the subtle intra- or interprotein interactions induced by the initial solvent conditions. In
other words, the balance of protein−protein vs protein−solvent interactions present in the initial solution conditions is a critical
driving force for fibril formation.
■ INTRODUCTION
Neurodegeneration is often associated with a class of diseases
known as proteopathies or foldopathies, in which specific
proteins oligomerize and aggregate to form fibrils.1−4 Examples
of these proteins include α-synuclein,5 huntingtin,6 amyloid-
β,3,7 and tau.8−10 Hereof, tau is an intrinsically disordered
protein found in neuronal cells that plays an important role in
the formation and stabilization of the microtubule cytoskeleton.
The carboxyl region of adult-specific human tau contains four
imperfect repeats (Figure 1A). This repeat region possesses
inherent microtubule binding and microtubule stabilizing
activities. Interestingly, this region also contains sequences
that form the intertau cross β-sheets that are essential for the
pathological tau aggregation process to fibrils.
It is widely held that aberrant tau dissociates from
microtubules and then self-aggregates10−12 to form oligomers,
intermediate aggregates, and mature fibrillar pathological
structures packed into cross-β conformations. However, the
nature of the aggregation seeding mechanism is unclear. Is it a
shift in monomer/dimer equilibrium toward an aggregation
prone conformation as suggested in the nucleation conforma-
tion transition model?13 Or is it an increased concentration of
oligomers/fibrils that template monomers as suggested by the
nucleation polymerization model?14,15 Remarkable recent work
demonstrates that pathological tau (of ill-defined structure) is
transferred from one neuron to the next along synaptic circuits,
leading to the trans-synaptic progression of tau pathology and
the disease state.16−18 Once pathological tau is taken up by the
naive postsynaptic neuron, it serves as a seed to promote
aggregation of the endogenous, nonpathological tau. This
newly formed pathological tau may be itself toxic or may cause
toxicity through loss-of-function effects as it converts
endogenous normal tau to a nonfunctional state. Whatever
the exact mechanism of tau toxicity, there is increasing evidence
that protein aggregation to fibrils and their specific cross β-
sheet structure are reflective of tau pathology.19,20 Taken
together, tau misfolding, oligomerization, and aggregation are
obligatory components of tau-mediated pathogenesis. It follows
that acquiring a better understanding of the driving forces for
aggregation, starting from monomers in solutionof whichever
tau protein or fragment that aggregates to form cross β-sheet
structured fibrilsis of fundamental importance.
While it would be preferable to study tau oligomerization and
aggregation using full-length tau, its large size and disordered
nature exclude access to many biophysical techniques that offer
molecular-level insight. Hence, we have chosen to examine a
tau fragment known to be important for the aggregation
process, 273GKVQIINKKLDL284 (herein referred to as “R2/
WT”).21,22 This peptide contains 275VQIINK280 (also known in
the literature as “PHF6*”), one of two related hexapeptide
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units located in the microtubule binding region (Figure 1B)
and known to form interprotein β-sheet contacts that are
essential to the tau aggregation/fibrillization process.21,23,24
Previous work has shown that 275VQIINK280 can form fibrils
when aggregation is triggered by heparin, with morphology
indistinguishable from the fibrils formed by full-length human
tau.23,25,26
It was verified that R2/WT peptide, like its full length
counterpart, is intrinsically disordered, populating a range of
conformations from compact to extended.22 The same study
proposes that the compact structures of R2/WT peptides are
stabilized by hydrogen bonds or by salt bridges between the K
and D residues.22 Importantly, it has been suggested in the
literature that intrinsically disordered peptides can adopt
aggregation-prone conformations (N* structures) and that
shifting the population toward N* conformations increases
aggregation rates.27−30 Most studies to date in which
populations of monomers are directed toward aggregation-
prone states have focused on the effect of point mutations or
chemical linkers.31−33 In this paper, we test the hypothesis that
similar effects can be achieved by tuning the initial solution
conditions of the sample. We demonstrate on model tau
fragments R2/WT and R2/G273C that subtle changes in
solution conditions, such as the addition of osmolytes or
changes in buffer type, influence the aggregation pathways and
end products.
Our experimental strategy is to elucidate the conformational
state, population, and aggregation process by probing events at
time scales spanning seconds to hours after the initiation of
aggregation, with assembly states covering the monomer,
dimer, and fibril dimensions. Replacement of the terminal
glycine residue of R2/WT with cysteine to form 273CKVQ-
IINKKLDL284 (Figure 1C) allows the formation of nitroxide
spin-labeled peptide G273C-SL with the structure shown in
Figure 1D. As we will show, this modification does not
significantly alter the properties of the peptide compared to
R2/WT but allows us to use electron paramagnetic resonance
(EPR) line shape analysis to probe the solvent accessibility,
packing, and mobility of the spin-label as well as to quantify the
% populations of mobile vs β-sheet embedded spin-labeled
peptides, before and after the initiation of aggregation. This
decomposition into mobile vs β-sheet embedded populations is
made possible by the clear appearance of a spin-exchanged
single line feature in the EPR spectrum of G273C-SL when
subject to aggregating conditions, whose population dramati-
cally increases with aggregation time. Such single-line EPR
features, observed with singly spin-labeled proteins or peptides
subject to fibrillization, have been unambiguously attributed to
β-sheet packing of the spin-labeled sites in the literature.34 The
same spin-labeled peptide is concurrently used to carry out
Overhauser dynamic nuclear polarization (ODNP) relaxometry
to monitor the surface water diffusivity within 10 Å of the spin-
label. The translational diffusion of surface water necessarily
involves hydrogen bond breaking, spatial displacement, and
hydrogen bond reforming of water and thus reports on the
strength of the dynamic surface water network that is governed
by both the adhesive energy between the peptide surface and
water and the cohesive energy of water lining the peptide
surface. Crucially, this implies that ODNP is sensitive to
detecting conformational changes of the peptide (or shifts in
the population of different conformations) that alter the
balance between peptide−water and peptide−peptide attrac-
tion, even in the absence of significant conformational changes
or aggregation that physically buries the spin-label. Such studies
are consistent with recent neutron scattering experiments on
full length tau which have shown that translational water
diffusivity is sensitive to the aggregation state of tau.35 Ion
mobility mass spectrometry (IM-MS) is used to measure the
relative populations of hydrated tau monomers, dimers, and
higher order assemblies.36 And finally, transmission electron
microscopy (TEM) and thioflavin T (ThT) fluorescence
spectroscopy are used to assess β-sheet-rich aggregate content
under various solution conditions, i.e., in the presence of
osmolytes such as urea vs TMAO, or when different buffers
such as acetate or phosphate vs salt-free water solvate the
peptide. The question we address is whether or not the
relatively subtle intra- or interprotein interactions that are
present under the initial solvent conditions have a significant
influence over the subsequent dramatic aggregation process
induced by heparin. Our results follow.
■ EXPERIMENTAL METHODS
Materials. Peptides were synthesized by Genscript Corp.
(Piscataway, NJ) with N-terminal acetylation and C-terminal
amidation in order to remove the electric charges on the ends
of the peptide. The nitroxide probe (1-oxyl-2,2,5,5-tetramethyl-
pyrroline-3-methyl)methanethiosulfonate spin-label (MTSL)
was purchased from Santa Cruz Biotechnology (Dallas, TX).
Urea was purchased from Affymetrix, Inc. (Cleveland, OH).
Tetramethylamine N-oxide (TMAO) was purchased from
Acros Organics (Fair Lawn, NJ). Heparin (6 kDa average
molecular weight) was purchased from Sigma-Aldrich (St.
Louis, MO). PD MidiTrap G-10 desalting columns were
purchased from GE Healthcare (Wauwatosa, WI). Thioflavin-T
(ThT) was purchased from AnaSpec Inc. (Fremont, CA).
Peptide Spin-Labeling. To prepare R2/G273C-SL, R2/
G273C was dissolved in 6 M guanidine hydrochloride in order
to prevent aggregation during the labeling process. MTSL,
dissolved in dimethyl sulfoxide (DMSO), was added in excess
Figure 1. (A) Diagram of full-length four-repeat (“4R”) tau consisting
of 441 amino acids, the longest isoform in the human central nervous
system. This isoform has a projection domain containing two
alternatively spliced exons (E2 and E3) as well as a proline-rich
region and four pseudorepeats in the microtubule binding repeat
region (MTBR). (B) Diagram of the MTBR showing the location and
sequence of the two hexapeptide units (PHF6* and PHF6). (C)
Sequence of peptides used in this study including the wild type (WT)
and singly mutated versions. (D) Structure of spin-label (MTSL),
which is attached to R2/G273C via a disulfide bond on the cysteine.
Adapted in part from ref 28.
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to the peptide (×10 molar concentration). The labeling process
was allowed to occur overnight at 4 °C. Excess spin-label and
guanidine hydrochloride were then removed using a PD
MidiTrap G-10 desalting column, while exchanging the peptide
into pure water. Finally, the spin-labeled peptide was
lyophilized and stored at −20 °C until ready to use. The
peptide was then dissolved in the desired buffer.
Overhauser Dynamic Nuclear Polarization (ODNP).
ODNP measures the local water dynamics with site-specific
resolution of 5−10 Å (2−4 hydration layers) around a spin-
label which is attached to a single cysteine of a peptide or
protein.37 ODNP measurements of R2/G273C-SL were carried
out at 0.35 T corresponding to a proton Larmor frequency of
14.8 MHz and electron Larmor frequency of 9.8 GHz. A 3.5 μL
sample was loaded into a 0.6 mm i.d., 0.84 mm o.d. quartz
capillary tube (VitroCom), sealed at one end with beeswax and
the other end with critoseal, and attached to a home-built NMR
probe. The probe was connected to a Bruker Avance
spectrometer and held inside the dielectric (ER 4123D) EPR
resonator. In order to avoid heating caused by microwave
irradiation, room-temperature air was blown over the sample.
ODNP was performed by continuously pumping microwave
irradiation at 9.8 GHz, thus saturating the nitroxide central EPR
transition, while simultaneously recording proton NMR signal
at 14.8 MHz. Proton spin−lattice relaxation times, T1, were
obtained using an inversion−recovery pulse sequence.
An in-depth description of ODNP theory can be found in the
literature, and so only a brief overview is given here.38,39 The
general idea of ODNP is to transfer the high spin polarization
of an unpaired electron, supplied by a site-specific nitroxide
spin-label, to the protons on water which are in close proximity
upon saturation of the EPR transition (i.e., the Overhauser
effect), thus greatly amplifying the NMR signal of water. The
negative NMR signal enhancement can only be observed when
the translational diffusion of water is rapid enough to induce
dipolar relaxation with the electron spin of nitroxide spin-labels.
This enhancement in NMR signal at maximum saturation, Emax,
can be written as
ξ
γ
γ
= −E s f1max max e
H (1)
The value of interest from this equation is the coupling factor,
ξ, which is used to determine dynamics and subsequently the
diffusion coefficient. The saturation factor of the electron spin
is described by s. We have previously found that smax = 1 is valid
when nitroxide spin-labels are tethered to slow tumbling
molecules or assemblies, such as proteins.38 The leakage factor,
f, describes the efficiency with which the electron spin facilitates
the proton nuclear spin relaxation and can be described by f = 1
− T1/T10, where T1 and T10 are the spin−lattice relaxation
times in the presence and absence of the spin-label,
respectively. Finally, the parameter γe/γH is the ratio of the
electron and proton larmor frequencies which is equal to 658.
One important challenge of quantifying the coupling factor is
that determination of the leakage factor is highly error prone if
the T1 relaxation time is dominated by the contribution of T10,
as found in samples with low spin-label concentrations. This
error can lead to inaccurate measurements of the coupling
factor and therefore also the local diffusion coefficient. Thus, in
this study we instead use a new ODNP analysis method which
has been previously described to calculate the relaxivity
constant, kσ, which reports on the fast (picoseconds) time-
scale dynamics around the spin-label.39
γ
γ
= −σk
E
C T
1 max
SL 1
H
e (2)
where CSL is the spin-label concentration. It has been shown
previously how kσ relates to the translational correlation time of
water, τc, by writing it in terms of the spectral density function,
J(ω,τc), of the dipole−dipole Hamiltonian.
40
τ γ γ τ γ γ τ= − − +σk B J B J B( , ) 6 (( ) , ) (( ) , )0 c e H 0 c e H 0 c (3)
where B0 is the magnetic field. Thus, changes in kσ can be
unambiguously assigned to changes in the diffusion dynamics of
loosely bound hydration water which reports on protein
conformational changes and interprotein interactions. Even
though the analysis of kσ does not yield the diffusion coefficient,
it is a very useful scale with high values of kσ indicating faster
and low values indicating slower diffusing local hydration water
around the spin-labels.
Lyophilized samples of R2/G273C-SL were dissolved in 20
mM ammonium acetate buffer (pH = 7.0), sodium phosphate
buffer (pH = 7.0), or water to a concentration of 400 μM. For
samples after aggregation, heparin is added at a molar ratio of
4:1 (peptide to heparin), which is a widely used practice to
induce aggregation and fibrillization of tau peptides and
proteins.41 For the study involving urea or TMAO, these
osmolytes were added to the solution of tau peptides at 4.4 and
2 M concentrations, respectively.
Electron Paramagnetic Resonance (EPR). Continuous
wave EPR is capable of probing mobility of the spin-label as
well as its accessibility to solvent. All EPR spectra were acquired
using a Bruker EMX X-band spectrometer and dielectric
(ER4123D) cavity. A 3.5 μL sample was loaded into a capillary
and sealed at one end with beewax and the other with critoseal.
The sample was then irradiated with 6 mW of microwave
power at 9.8 GHz using a 0.3 G modulation amplitude and a
sweep width of 150 G. Sample preparation and conditions were
the same as for the ODNP experiment.
EPR Simulation. EPR simulation is able to fit experimental
EPR data to either single or multiple components and was used
to determine percent β-sheet content. EPR simulation was
completed using the MultiComponent software of Dr.
Christian Altenbach. In each spectra, the A tensors were fixed
at Axx = 6.2, Ayy = 5.9, and Azz = 37 while the g tensors were
fixed at gxx = 2.0078, gyy = 2.0058, and gzz = 2.0022 which have
been previously determined for MTSL.42 The rotational
correlation time, R, and the order parameter S were used as
fit parameters. In the case of a two-component fit, the
Heisenberg spin exchange frequency (ω) was allowed to vary in
order to obtain a single line component.
Ion Mobility Mass Spectrometry (IM-MS). Nanoelec-
trosprayed ionization (n-ESI) IM-MS is a method capable of
detecting multiple conformations of the same species and
oligomers at different sizes having the same mass to charge (m/
z) ratios. The ions are generated by ESI, captured, and stored in
an ion funnel and subsequently pulsed into a drift cell filled
with He gas at high pressure (∼12−13 Torr). The ions
experience collisions with the buffer gas molecules and
additional force due to a weak electrical field. These combined
effects allow the ions to drift with a constant velocity which can
then be related to the reduced mobility K0 independent from
instrumental parameters. This value can be used to calculate the
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absolute collision cross sections σ given the size n and charge z
of the species.43,44
π= +
Ω
⎡
⎣⎢
⎤
⎦⎥K m m
ze
k T N
(18 )
16
1 1
( )
1 1
0
1/2
b
1/2
B
1/2
avg (4)
where m and mb are the molecular weights of the ions and
buffer gas molecules, respectively, ze is the charge of the ion, N
is the buffer gas density, and Ωavg is the average collisional cross
section integral, which approximates to be the same as the
average collision cross section σ. The IM-MS instrument was
built in-house and consists of a nano-ESI source, an ion funnel,
a 2 m long drift cell, and a quadrupole mass filter.45
Lyophilized samples of R2/WT and R2/G273C-SL were
dissolved in 20 mM ammonium acetate buffer (pH = 7.0),
sodium phosphate buffer (pH = 7.0), or water, depending on
the sample of study, to a concentration of 100 μM. For the
experiments involving heparin or urea, the concentration of
protein samples was reduced to 50 μM. When urea was present,
the concentration of urea was kept constant at 1.1 M, so that
the ratio of protein to urea is the same 4:1 for all experiments
including ODNP, EPR, and TEM.
Transmission Electron Microscopy (TEM). TEM was
used to visualize aggregates at nanometer scales. Images were
obtained using a JEOL-1230 model microscope coupled to an
ORCA camera with AMT Image Capture Software Version
5.24 (Advanced Microscopy Techniques, Woburn, MA).
Unless otherwise noted in the text, aggregation mixtures
contained 100 μM peptide and 25 μM heparin in 20 mM
ammonium acetate buffer (pH = 7.0), 20 mM sodium
phosphate buffer (pH = 7.0), or water, depending on the
sample of study. Samples of these mixtures were removed after
some amount of time (generally 24 h) and fixed for 5 min in
1.6% glutaraldehyde (Ted Pella, Inc.). Fixed samples were
placed on TEM grids (300 mesh, Formvar/copper, Electron
Microscopy Sciences) for 1.5 min, rinsed with water, and then
stained for 20 s with 2% uranyl acetate (Ted Pella, Inc.). The
physical dimensions of aggregates were measured using
unaltered images and ImageJ software (version 1.47b, NIH).
Statistics were carried out using the GraphPad Prism software.
Thioflavin T Assay. Thioflavin T is a fluorescent dye that
undergoes a shift in excitation and emission maxima upon bind
to and detect β-sheet amyloid structures and is therefore useful
for monitoring the kinetics of tau aggregation. A ThT stock
solution (3 mM) was prepared in water and stored in the dark.
Mixtures of peptide (50 μM) with and without heparin (12.5
μM) were prepared in either 20 mM ammonium acetate buffer
(pH = 7.0) with or without urea (4.4 M) or TMAO (2 or 0.2
M), 20 mM sodium phosphate buffer (pH 7.0), or water
containing ThT (2.2 μM). ThT fluorescence was measured at
450ex/488em emission in a Tecan M220 Infinite Pro
microplate reader. Data presented are the average of five
independent experiments. Although the data are presented in
two separate figures for organizational purposes, all exper-
imental conditions were included in each experiment. To
account for any differences in baseline signal arising from the
various buffers and osmolytes, as well as for experiment-to-
experiment variability in the strength of fluorescence signal, the
t = 0 value of the appropriate “no heparin” condition was
subtracted from each time point (both + and − heparin).
■ RESULTS AND DISCUSSION
Aggregation Propensity of R2/WT and R2/G273C-SL.
We first used TEM to assess the relative abilities of R2/G273C-
SL and R2/WT peptides to form fibrillar aggregates in the
presence of heparin and to compare the morphologies of the
fibers produced. Without heparin, neither peptide forms
substantial aggregates or fibrils during the time course of the
Figure 2. TEM comparison of R2/G273C-SL and R2/WT fiber formation in the absence of heparin (A and D, respectively) and in the presence of
heparin (B and E, respectively). A comparison of fiber morphology is shown in (C and F) for R2/G273C-SL and R2/WT, respectively, with black
arrows showing PHF-like fibers, white arrows showing individual straight fibers, and stars signifying bundled fibers. All peptides were dissolved at 100
μM in 20 mM ammonium acetate buffer, pH 7.0, and 25 μM heparin (6 kDa) was used at a 1:4 molar ratio with respect to peptide. (A, B, D, and E)
scale bar = 250 nm; (C and F) scale bar = 100 nm.
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experiment (Figure 2, panels A and D). Upon heparin addition
and subsequent incubation for ∼24 h, both peptides form
fibrillar aggregates (Figure 2, panels B and E). Higher
magnification reveals that each peptide forms a combination
of twisted, “paired helical filament”-like46 fibers, individual
straight fibers, and bundled straight fibers that run parallel to
each other (Figure 2, panels C and F). For a more quantitative
comparison of fiber morphology, we compared the widths of
individual straight fibers made of R2/G273C-SL vs R2/WT.
The fiber widths were nearly identical: R2/G273C-SL fibers
had an average width of 9.9 nm ± 0.17 SEM (N = 71), while
R2/WT fibers had an average width of 9.7 nm ± 0.15 SEM (N
= 129). This difference is not statistically significant. Notably,
these dimensions fall within the prototypical range found for a
variety of amyloid fibrils.47 Taken together, the TEM data
indicate that at the macroscopic length scale R2/G273C-SL and
R2/WT derived fibrils are indistinguishable.
Next, we compared IM-MS data of the two peptides. In the
absence of heparin, the mass spectra indicate that both peptides
exist predominantly in two charge states: n/z = 1/3 and 1/2.
n/z = 1/2. The arrival time distribution (ATD) of R2/
G273C-SL peptide contains two features (Figure 3D). The
ATD features are similar to those of the R2/G273C peptide
(containing no MTSL probe, data not shown), suggesting that
the short arrival time is a dimer and the other feature is a
monomer. The dimer species with n/z = 2/4 is more abundant
with R2/G273C-SL compared to R2/WT (see Figure 3D vs
3B, respectively). The cross sections of the spin-labeled
peptide’s monomer and dimer (n/z = 1/2 and 2/4) are both
∼12.5% larger than those of the WT reflecting the presence of
the spin-label.
n/z = 1/3. The ATD of the R2/WT contains a single peak
that is assigned as a monomer (Figure 3A). However, the ATD
of the R2/G273C-SL peptide is more complex. The possible
reason for this complexity is discussed in the Supporting
Information. The important point is that the dominant peak at
the shortest arrival time is a monomer. Its cross section is
comparable to that of the R2/WT monomer, which is
somewhat surprising given the results of the n/z = 1/2 mass
peak, and indicates a more compact fold than R2/WT. The
feature with the longest arrival time has a cross section of σ =
380 Å2. This is likely an extended conformation of the fully
protonated species. Another possibility is that this feature
corresponds to a water bound monomer in which the water
molecules were dissociated before reaching the detector, as
previous observed in another system.48
Importantly, the IM-MS data show the predominant
population of both peptides is monomeric with comparable
conformations, while TEM data show the fibrillar end point of
R2/WT aggregation is preserved upon mutation and spin-
labeling. On the basis of the above-described comparison of
R2/WT and R2/G273C-SL, we conclude they are sufficiently
similar so that conclusions based on biophysical analysis of R2/
G273C-SL can be extrapolated to R2/WT.
Effects of Osmolytes on Oligomeric State and
Aggregation Propensity. We first examine the changes in
R2/G273C-SL aggregation at the macroscopic scale in the
presence of the osmolyte urea (a standard chaotrope) or
TMAO (a standard kosmotrope). In the absence of osmolytes,
R2/G273C-SL in acetate buffer forms abundant fibrillar
aggregates upon heparin addition (Figure 4A). The addition
Figure 3. Representative ATDs at n/z = 1/3 and 1/2 of 12-mer R2/
WT (m/z = 469 for panel A and 705 for panel B), R2/G273C-SL (m/
z = 546 for panel C and 820 for panel D) peptides, and R2/G273C-SL
with 1.1 M urea (m/z = 546 for panel E and 820 for panel F). The
peptides are dissolved in 20 mM ammonium acetate buffer at pH =
7.0. Each feature is labeled with oligomer size (M = monomer, D =
dimer) and experimental cross section (σ, Å2).
Figure 4. TEM showing the effect of osmolytes on R2/G273C-SL
fiber formation. TEM of fibers formed after 24 h of incubation of
peptide (100 μM) with 6 kDa heparin (25 μM) in 20 mM ammonium
acetate buffer alone (panel A), plus 2 M TMAO (panel B), 0.2 M
TMAO (panel C), or 4.4 M urea (panel D). Scale bar = 100 nm.
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of 2 M TMAO (Figure 4B) resulted in qualitatively more fibrils
than 0.2 M TMAO (Figure 4C) or buffer alone. In the presence
of urea (4.4 M), fibril formation is largely prevented, with
smaller quantities of fibrillar species observed (Figure 4D).
Consistent with the TEM results, ThT assays demonstrate that
R2/G273C-SL forms β-sheet-rich aggregates in the presence of
heparin, that urea significantly slows aggregation, and that
TMAO promotes aggregation in a concentration-dependent
manner (Figure 5). The initial drop in signal for R2/G273C-SL
in 2 M TMAO is attributed to aggressive rapid clumping,
initially upon mixing, thereby excluding ThT from binding. In
the absence of heparin, the peptide in all buffer conditions
shows no increase in ThT signal over 14 h.
Next, using IM-MS, we focus on the osmolyte-induced
differences in tau peptide conformations and populations prior
to the addition of heparin. IM-MS analysis in the presence of
TMAO was unsuccessful, as even at low TMAO concentrations
and short time scales we consistently encountered technical
problems due to clogging of the capillary electrospray tips,
consistent with the rapid formation of tau oligomers or
aggregates. In contrast, in the presence of urea, the ATDs at m/
z = 820 indicate the population of dimers, which was ∼30% of
the total population to begin with is further reduced to
approximately 15%, as determined from the reduced signal
intensity of the dimer feature relative to the monomer feature
(Figure 3, panels F vs D). This suggests that urea breaks apart
interprotein contacts within dimers, thereby shifting the
population toward monomers. These results are consistent
with computational studies showing that aggregates are
destabilized in the presence of urea.49−51 MD simulations of
the R2/WT peptide in urea have shown that urea binds to the
peptide backbone and side chains, impeding the peptide’s
ability to form compact intra- or interpeptide hydrogen bonded
structures, leading primarily to extended conformations and
preventing inter-tau bond formation.51
Upon addition of heparin to the solution, IM-MS data show
that unresolved tau/aggregate peaks appear at time t = 0−15
min in the high m/z region of the mass spectrum around
1000−2000 (Figure 6A). At 1.5 h, the high m/z signal increases
significantly, representing vigorous aggregation to form soluble
oligomers. When the peptide has been allowed to aggregate for
2 days, the intensities decrease significantly, suggesting that the
majority of the peptide monomer and oligomers have been
converted to aggregates that can no longer be detected by MS
(Figure 6A, top row), most likely due to the formation of
insoluble fibrils. The ATD data in the second and third rows of
Figure 6A show that at time t = 0−15 min peptide oligomers of
intermediate sizes can be found at m/z = 546 (n/z = 1/3),
which quickly deplete to transform into larger size oligomers
with lower charges at m/z = 820 (n/z = 1/2). Oligomers
gradually continue to form over the entire time scale of the
experiment, presumably due to their lower charge states. In
contrast, the mass spectral data in the presence of urea (Figure
6B) show no fingerprints of larger aggregates, even 2 days after
heparin addition, while the ATD data show only a dimer peak
at m/z = 820 across all time points. A small trace of oligomers
larger than a dimer appears at t = 1 h in the presence of urea
but does not increase in intensity with additional incubation
time. Here, the IM-MS data together with TEM and ThT data
confirm that adding urea shifts the tau peptide population
toward monomer in the presence of heparin and strongly
disrupts inter-tau interactions and reduces β-sheet formation.
Apparently, the solution conditions that drive tau conformation
toward monomer populations also hinder the formation of
higher order oligomers and aggregates, even upon heparin
addition. While the addition of heparin facilitates aggregate
formation, this effector does not override the common
molecular level interactions engrained in the solution
conditions that appear to dictate interprotein interactions at
the monomer, dimer, and higher order oligomer level.
Finally, we seek to measure the peptide surface’s local
environment by ODNP relaxometry,38 which reports on the
translational diffusivity of surface water near the spin-labeled
site of the R2/G273C-SL peptide by means of an electron−1H
cross-relaxivity parameter, kσ, as defined in the literature.
52,53
The reference value is the surface water diffusivity of the R2/
G273C-SL peptide in bulk solution state before the addition of
heparin and in the absence of osmolytes. Under these
conditions, we know from IM-MS data that R2/G273C-SL
predominantly exists as monomers, as previously discussed
(Figure 3C,D), while quantitative EPR line shape analysis
verifies the spin-label is mobile and fully solvent-exposed. Most
importantly, EPR finds the spin-label is represented by a single
mobile population (see Figure 7a and Supporting Information
Figure S4), warranting the interpretation of the ODNP
parameter kσ in terms of water dynamics. The kσ value of the
R2/G273C-SL surface in acetate buffer, without added heparin
or osmolytes, is 20.8 ± 1.0 s−1 M−1 (Figure 8). When heparin is
added, the peptide surface water diffusivity or accessibility
dramatically slows within the experimental dead time (∼
minutes), as reflected in the lowering of kσ to 2.5 ± 2.3 s
−1 M−1.
This value remains unchanged throughout the 24 h time course
of the experiment during which aggregation proceeds. This
implies that upon addition of heparin the peptide assumes a
local conformation in which the spin-label is partially buried
Figure 5. Thioflavin T fluorescence reveals effects of heparin and
osmolytes on tau aggregation. Top panel is full scale while the bottom
panel is zoomed in to show the first 30 min. The spin-labeled tau
peptide R2/G273C-SL (25 μM) was incubated in 20 mM ammonium
acetate buffer, pH 7.0, in the presence or absence of 6 kDa heparin
(6.25 μM), TMAO (2 M), TMAO (0.2 M), and urea (4.4 M). All four
non-heparin conditions generate identical and overlapping ThT
signals, and so only one is shown for simplicity. Data shown are
averaged from five separate experiments.
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from the solvent. Hence, the local environment of the spin-label
does not further change with macroscopic aggregate formation.
In contrast, when urea is present at 4.4 M, the hydration
dynamics of the R2/G273C-SL surface are significantly more
active even before heparin is added, as reflected in kσ = 38.0 ±
1.2 s−1 M−1 (Figure 8). This increase in surface water dynamics
in the presence of urea can only be in part due to the breaking
apart of dimer populations that result in the spin-label being
more exposed to the solvent. As previously described, IM-MS
results show that the dimer population in the presence of urea
is reduced to half of its initial, already small, dimer population.
MD simulations of the wild-type peptide have shown that
monomers in urea are more extended than in the absence of
urea.51 Quantitative EPR analysis further verifies that the
narrow line shape remains unaltered and that the EPR
spectrum of G273C-SL before heparin addition consists of a
single mobile population, with or without urea (compare Figure
7, panel a vs d; also see Supporting Information Figure S4).
Thus, the observed change in kσ (Figure 8) cannot be simply
due to the increased exposure of spin-label in the presence of
urea. Instead, the dramatic increase in the tau peptide’s surface
water diffusivity in the presence of urea is attributed to a
weakened interaction between the peptide surface and the
water hydrating the peptide surface and the weakened cohesion
between water molecules of the dynamic hydration network
near the peptide surface. The interpretation that urea weakens
the peptide’s surface water network is further corroborated by
reference measurements of the spin probe in solution alone (in
the absence of peptide), where local water diffusivity slows in
the presence of urea, as verified with a decrease in the value of
kσ (see Table S1; from kσ = 56.6 ± 0.5 s
−1 M−1 for acetate
buffer to kσ = 33.4 ± 0.4 s
−1 M−1 for 4.4 M urea dissolved in
Figure 6. ESI-q-mass spectra of 50 μM G273C-SL in 12.5 μM 6 kDa heparin with and without 1.1 M urea dissolved in 20 mM ammonium acetate
buffer. (A) In the absence of urea, large oligomers are detected at both n/z = 1/2 and 1/3 ATDs. The mass spectra show high signal-to-noise at high
m/z indicating the prevalence of large and unresolved aggregates. Note the presence of a minor peak at n/z = 1/2, which likely represents an R2/WT
impurity. (B) The presence of urea suppresses the aggregation process, as indicated by no significant changes in the mass spectra or ATDs after 2
days.
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acetate buffer). The measured effect of urea decreasing the local
water diffusivity near the free spin probe in bulk aqueous
solution is expected, as urea is known to increase the bulk water
viscosity by more than 20% at 4.4 M.54
When heparin is added to the solution of R2/G273C-SL in
the presence of urea, the surface hydration dynamics slow
dramatically over a period of several hours to yield kσ of 6.1 ±
0.3 s−1 M−1. Again, this change suggests that even in the
presence of urea the peptide assumes an altered local
conformation in which the spin-label is buried from the solvent
and/or experiences an altered topological environment once
aggregation is initiated. It is interesting that the changes do not
result in significant aggregate formation as detectable by TEM,
ThT, and IM-MS. Quantitative EPR line shape analysis finds
that the characteristic single-line EPR feature signifying
immobilized spin-labels embedded in parallel β-sheet structures
increases from 0 to ∼50% within 15 min of adding heparin,
even in the presence of urea (see Figure 7, panels d−f). This
means a significant population of the tau fragments stack in β-
sheet arrangements in the presence of urea when heparin is
added, even though urea largely hinders the growth to larger
fibrillar assemblies detectable by TEM or ThT staining.
Consistently, the ATD data in the presence of urea hint at
the formation of small populations of higher order assemblies
(Figure 6B). Notably, the kσ value in the presence of urea is
higher across all aggregation times compared to without,
implying a higher surface water diffusivity experienced by the
spin-label regardless of the tau conformation or oligomer
distribution in the presence of heparin. This suggests that urea
nonspecifically weakens the strength of the hydration water
structure near the surface of the peptide.
TMAO (2 M) has the opposite effect on surface water
diffusivity near the terminal site of R2/G273C-SL. Even before
the addition of heparin, the hydration dynamics in the presence
of TMAO are slowed significantly, as represented by a kσ value
of 6.3 ± 0.9 s−1 M−1 (Figure 8). The reference measurements
of free spin probes in acetate buffer containing the same
TMAO concentration show that kσ changes from 56.6 ± 0.5 to
31.5 ± 0.4 s−1 M−1, which is consistent with an increase in bulk
water viscosity by TMAO, similar to the changes observed
when 4.4 M urea was added. Thus, the contrasting effects of
TMAO and urea at the peptide surface are even more striking,
especially given the much more dramatic decrease in the kσ
Figure 7. Experimental EPR spectra together with quantitative line shape simulation and analysis of 400 μM R2/G273C-SL in 20 mM ammonium
acetate buffer, pH 7.0, and 100 μM 6 kDa heparin with no osmolytes (a−c), 4.4 M urea (d−f), or 2 M TMAO (g−i) before heparin addition (a, d,
and g, respectively), 10 min after heparin addition (b, e, and h, respectively), and 24 h after heparin addition (c, f, and i, respectively). Also shown is
the peptide dissolved in water and 20 mM phosphate buffer, pH 7.0, before heparin addition (j and k, respectively). Experimental EPR data are
shown in black, the total simulated EPR spectrum is shown in red, the mobile component of the simulation is shown as a blue dotted line, and the
immobile component is shown in green. For each spectrum, the derived % population of the mobile (M) and immobile (I) components is listed.
Figure 8. ODNP time course of 400 μM R2/G273C-SL in 20 mM
acetate buffer, pH 7.0, and 100 μM 6 kDa heparin with either no
osmolytes, 4.4 M urea, or 2 M TMAO. Note the connecting line from
before to after heparin addition is meant as a guide. Inset: EPR spectra
taken of all three conditions after 24 h and normalized by their
respective second integrals.
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value at the peptide surface when TMAO is added to the
solution of the peptide, compared to in bulk solution. The
effects of TMAO vs urea are therefore not that of altering bulk
solution properties, but rather a result of their distinct
interactions with the peptide surface and the peptide surface’s
hydration water. Specifically, the significantly depressed kσ value
even in the absence of heparin suggests that TMAO facilitates
partial intraprotein folding and/or protein−protein interaction,
thereby limiting the solvent accessibility of water to the spin-
label tethered to the peptide surface. In fact, quantitative EPR
line shape analysis finds that G273C-SL before heparin addition
already contains a significant, single-line, immobile component
(Figure 7, panel g). This population further increases to
consume nearly 100% of G273C-SL, after a few hours upon
heparin addition. This is consistent with the observation that
the peptides in the presence of TMAO, even before the
addition of heparin, could not be studied by IM-MS due to
formation of assemblies that clogged the IM-MS tip. Within
minutes of adding heparin, the value of kσ that reflects on
surface water diffusion further drops to around the same value
as that for the peptide in its fully aggregated state (kσ = 0.4 ±
0.1 s−1 M−1). This illustrates that the spin-label, within minutes
of adding heparin, quickly experiences a local packing and
topological environment indistinguishable from a mature fibril.
Effects of Solution Buffer on Oligomeric State and
Aggregation Propensity. Next, we test the effects of more
subtle modulators of protein conformation by varying the
buffer composition. Surprisingly, when dissolving the peptide in
solvents of 20 mM phosphate buffer (pH = 7), 20 mM acetate
buffer (pH = 7) vs water, stark differences were observed at all
stages of aggregation, from the early population of tau in
solution before heparin addition to the quantity of macroscopic
fibrils. ThT assays show that R2/G273C-SL forms β-sheet
aggregates in the presence of heparin under all three solvent
conditions; however, clear differences are observed in the
amount of ThT active units formed, as seen in Figure 9. A
substantial amount of ThT activity is observed when the
peptide is dissolved in phosphate buffer and acetate buffer, and
much less activity is seen when the peptide is dissolved in only
water. While the ThT activity of aggregating tau in acetate
buffer was highly reproducible, ThT data of the peptide
dissolved in phosphate buffer were found to be variable, making
it difficult to compare the extent of aggregation in the two
buffers. Often, an initial drop was observed in the ThT signal of
G273C-SL samples in phosphate buffer or an initially slow
slope of increase in ThT amplitude observed as shown in
Figure 9 (green trace), followed typically by a higher ThT
amplitude in phosphate compared to acetate buffer, once
aggregation is mature. This may be attributed to kinetically
rapid aggregation in phosphate buffer, initially hampering the
access of ThT dye to the β-sheets of tau peptide aggregates,
similar to what we observed with R2/G273C-SL aggregation in
the presence of 2 M TMAO (Figure 5), or to the generation of
non-β-sheet aggregates.
TEM images (Figure 10 inset) show that R2/G273C-SL
aggregates and forms fibrils in all three solvent conditions. Still
in water, the fibril formation is not as vigorous as in phosphate
and acetate buffer. This is consistent with ThT assays which
show a higher increase in aggregation when R2/G273C-SL is
incubated with heparin in either acetate or phosphate buffer
compared to water. Interestingly, fibrils formed in phosphate
buffer tend to appear clumped, while fibrils formed in acetate
buffer are more evenly dispersed and highly reproducible. This
is a possible cause for the variability seen in the ThT data for
the peptide in phosphate buffer, as fibril clumping could
interfere with the access of the ThT to the fibrils or off-
pathway, non-β-sheet, aggregates may be not ThT-active.
Figure 9. Thioflavin T fluorescence reveals effects of heparin and solvent on tau aggregation. Top panel is full scale while the bottom panel is
zoomed in to show the first 30 min. The spin-labeled tau peptide R2/G273C-SL (25 μM) was incubated in 20 mM phosphate buffer (pH = 7.0), 20
mM ammonium acetate buffer (pH = 7.0), or water in the presence or absence of 6 kDa heparin (6.25 μM). All four non-heparin conditions
generate identical and overlapping ThT signals, and so only one is shown for simplicity. Data shown are averaged from five separate experiments.
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The IM-MS data for R2/G273C-SL are consistent with the
TEM results. Monomers occur at n/z = 1/3 and n/z = 1/2
while dimers only occur at n/z = 1/2 in all solvents. An analysis
of the ATDs indicates that monomer is dominant for water
solvent, preferred for ammonium acetate solvent and roughly
equivalent to dimer in phosphate solvent. This trend suggests
that in phosphate buffer interactions between the peptides and
aggregation is facilitated even before heparin is added.
In the absence of heparin, ODNP-derived surface water
diffusivity (Figure 10) is comparably high in acetate buffer or
water, as signified with a kσ of 20.8 ± 1.0 and 22.3 ± 0.9 s
−1
M−1, respectively, but much slower in phosphate buffer,
represented by a kσ of 9.9 ± 0.3 s
−1 M−1. This correlates well
with the IM-MS data trend that shows that the phosphate
buffer shifts the conformation toward higher dimer populations.
However, upon heparin addition, the water dynamics collapse
to the same value in all three solutions (kσ ∼ 1.2 s−1 M−1),
corresponding to the local solvent environment of the R2/
G273C-SL peptide surface topology in its aggregated state. The
control experiment of measuring local water dynamics near a
free spin-label, not tethered to a tau peptide, showed no
meaningful differences between phosphate buffer (kσ = 67.2 ±
0.3 s−1 M−1), acetate buffer (kσ = 56.6 ± 0.5 s
−1 M−1), and
water (kσ = 63.9 ± 0.4 s
−1 M−1). Even though there is an ∼16%
difference in kσ for the free spin-label between the acetate buffer
and phosphate buffer, this is a small difference compared to the
∼52% difference in kσ between the two buffers on the surface of
the tau peptide. Furthermore, the small change goes in the
opposite direction between these two buffers for the free spin-
label vs the spin-label on the tau peptide surface. This supports
the conclusion that the differences in kσ are due to differences
in the conformational population of tau peptides established in
different buffer solutions prior to the initiation of aggregation.
While IM-MS and ODNP data display clear contrast in the
conformational equilibrium of G273C-SL in the different
buffers prior to heparin addition, EPR line shape analysis
finds that G273C-SL is represented with a single, high-mobility,
population in acetate and phosphate buffer and water (Figure 7,
panels a, j, and k). Importantly, this demonstrates that it is not
the formation of higher order oligomers or aggregates under
different buffer conditions that seeds or facilitates fibril growth,
but indeed the shift in equilibrium toward aggregation-prone
solution species as reflected in increased dimer population, still
harboring highly mobile spin-labels, that is modulated by the
choice of buffers.
Overall, we find that downstream aggregation events are
highly sensitive to changes in early protein conformations and
oligomer populations, not only when adding osmolytes (i.e.,
urea and TMAO) with known effects on protein conformation
or protein−protein interactions55,56 but also when altering the
type of buffer, which is usually regarded a subtle or even
inconsequential detail in sample preparation for protein
aggregation studies. We conclude that the effect of the
respective solution conditions (i.e., buffers, osmolytes, etc.)
on the initial protein conformations and populations is a critical
factor, as they significantly and consistently affect the
oligomerization and aggregation properties of tau peptide
systems downstream. While we cannot exclude the possibility
that differing solution conditions may alter the interaction of
heparin with the peptide itself, this is believed to be a minor
factor given that the tau−heparin interaction is thought to be
mediated by dominant electrostatic interactions. Crucially the
main changes in dimer population or peptide−solvent
interaction with altered solution conditions occur before
heparin addition.
■ CONCLUSIONS
The aggregation process and accompanying transient changes
of tau are challenging to study experimentally, given that tau is
an intrinsically disordered protein with multiple monomeric
and small oligomeric populations coexisting in solution. Effects
that shift these populations, however, can have significant
consequences for tau aggregation and fibrillization. Here we
report on the study of tau peptide aggregation using a set of
techniques including TEM and ThT assays to characterize
amyloid fibril formation, IM-MS to derive tau populations in
solution and their cross sections, EPR line shape analysis to
quantify the population of mobile spin-labels vs immobile spin-
labels embedded in β-sheet structured interfaces, and ODNP-
derived surface water diffusivity/accessibility near the spin-label
of the tau peptide in situ as aggregation proceeds. Specifically,
we find that urea and TMAO both dramatically affect oligomer
formation and aggregation propensity of the short peptide R2/
G273C-SL, shifting the tau conformation and/or population in
opposite directions with regards to aggregation propensities.
IM-MS data and ODNP measurements find consistent results
that urea extends the tau conformation and breaks apart inter-
tau contacts and confirm that urea significantly weakens the
cohesive and dynamic water network hydrating the R2/G273C-
SL surface. Urea not only shifts the population toward
monomers but also persistently disrupts the surface water
network on the tau peptide and clusters near the tau surface
and so prevents inter-tau dimerization, as has been also recently
shown by a computational study.51 This is consistent with the
ODNP results that display weakened, and thus fast diffusing,
hydration water near the tau peptide surface, before as well as
after aggregation is initiated. The opposite effect is apparent in
the presence of TMAO. The presence of acetate and phosphate
buffers also shifts the tau peptide toward more aggregation
prone populations compared to water which, in turn, was
shown to affect the ability of the peptide to aggregate after the
addition of heparin. The observation that the initial
conformations induced via osmolytes or buffers affect
aggregation all the way through to the fibrillar state of the
peptide suggests that the factors modulating the competition
between solvent−protein and protein−protein interactions in
Figure 10. ODNP time course of 400 μM R2/G273C-SL in 20 mM
ammonium acetate buffer, 20 mM phosphate buffer, or water along
with 100 μM 6 kDa heparin where applicable. Inset: TEM of 100 μM
R2/G273C-SL in 20 mM ammonium acetate buffer, 20 mM
phosphate buffer, or water incubated with 25 μM 6 kDa heparin.
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solution state are essential factors that not only inf luence dimer
formation propensity but also downstream protein aggregation and
f ibril formation propensities. This suggests that it is not the
concentration of higher order oligomers or aggregates that
catalyzes or modulates aggregation and fibril growth as
proposed by the nucleation polymerization model,14,15 at
least in the case of the here-studied tau fragment. Even though
heparin drives aggregation kinetics dramatically toward fibril
formation, intrinsic interprotein interactions that are differ-
entially modulated by solution conditions persist throughout
the aggregation process.
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(42) Columbus, L.; Kaĺai, T.; Jekö, J.; Hideg, K.; Hubbell, W. L.
Molecular Motion of Spin Labeled Side Chains in A-Helices: Analysis
by Variation of Side Chain Structure†. Biochemistry 2001, 40, 3828−
3846.
(43) Mason, E. A.; McDaniel, E. W. Transport Properties of Ions in
Gases; John Wiley & Sons: New York, 1988.
(44) Gidden, J.; Ferzoco, A.; Baker, E. S.; Bowers, M. T. Duplex
Formation and the Onset of Helicity in Poly D(Cg)N Oligonucleo-
tides in a Solvent-Free Environment. J. Am. Chem. Soc. 2004, 126,
15132−15140.
(45) Kemper, P. R.; Dupuis, N. F.; Bowers, M. T. A New, Higher
Resolution, Ion Mobility Mass Spectrometer. Int. J. Mass Spectrom.
2009, 287, 46−57.
(46) Goedert, M.; Spillantini, M. G.; Cairns, N. J.; Crowther, R. A.
Tau Proteins of Alzheimer Paired Helical Filaments: Abnormal
Phosphorylation of All Six Brain Isoforms. Neuron 1992, 8, 159−168.
(47) Chiti, F.; Dobson, C. M. Protein Misfolding, Functional
Amyloid, and Human Disease. Annu. Rev. Biochem. 2006, 75, 333−366.
(48) Do, T. D.; Bowers, M. T. Diphenylalanine Self Assembly: Novel
Ion Mobility Methods Showing the Essential Role of Water. Anal.
Chem. 2015, 87, 4245−4252.
(49) Klimov, D. K.; Straub, J. E.; Thirumalai, D. Aqueous Urea
Solution Destabilizes Aβ16−22 Oligomers. Proc. Natl. Acad. Sci. U. S.
A. 2004, 101, 14760−14765.
(50) Cai, Z.; Li, J.; Yin, C.; Yang, Z.; Wu, J.; Zhou, R. Effect of Urea
Concentration on Aggregation of Amyloidogenic Hexapeptides
(Nfgail). J. Phys. Chem. B 2014, 118, 48−57.
(51) Levine, Z. A.; Larini, L.; LaPointe, N. E.; Feinstein, S. C.; Shea,
J. E. Regulation and Aggregation of Intrinsically Disordered Peptides.
Proc. Natl. Acad. Sci. U. S. A. 2015, 112, 2758−2763.
(52) Franck, J. M.; Pavlova, A.; Scott, J. A.; Han, S. Quantitative Cw
Overhauser Effect Dynamic Nuclear Polarization for the Analysis of
Local Water Dynamics. Prog. Nucl. Magn. Reson. Spectrosc. 2013, 74,
33−56.
(53) Hussain, S.; Franck, J. M.; Han, S. Transmembrane Protein
Activation Refined by Site-Specific Hydration Dynamics. Angew.
Chem., Int. Ed. 2013, 52, 1953−1958.
(54) Kawahara, K.; Tanford, C. Viscosity and Density of Aqueous
Solutions of Urea and Guanidine Hydrochloride. J. Biol. Chem. 1966,
241, 3228−3232.
(55) Candotti, M.; Esteban-Martin, S.; Salvatella, X.; Orozco, M.
Toward an Atomistic Description of the Urea-Denatured State of
Proteins. Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 5933−5938.
(56) Mello, C. C.; Barrick, D. Measuring the Stability of Partly
Folded Proteins Using Tmao. Protein Sci. 2003, 12, 1522−1529.
The Journal of Physical Chemistry B Article
DOI: 10.1021/acs.jpcb.5b08092
J. Phys. Chem. B 2015, 119, 14421−14432
14432
